Nakano, K., Hayakawa, K., Funauchi, Y., Tanizawa, T., Ae, K., Matsumoto, S., . . . Takahashi, S. (2021). Differences in the efficacy and safety of eribulin in patients with soft tissue sarcoma by histological subtype and treatment line. Mol Clin Oncol.
Chicago ZitierstilNakano, Kenji, et al. "Differences in the Efficacy and Safety of Eribulin in Patients With Soft Tissue Sarcoma By Histological Subtype and Treatment Line." Mol Clin Oncol 2021.
MLA ZitierstilNakano, Kenji, et al. "Differences in the Efficacy and Safety of Eribulin in Patients With Soft Tissue Sarcoma By Histological Subtype and Treatment Line." Mol Clin Oncol 2021.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.